Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alfred Hansel | M | 62 |
oncgnostics GmbH
 oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | 12 years |
| Kerstin Brox | F | - |
oncgnostics GmbH
oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | 12 years |
| Dana Schmidt | F | - |
oncgnostics GmbH
oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | 12 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthias Dürst | M | - |
oncgnostics GmbH
oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | - |
| Anne Nöldner | F | - |
oncgnostics GmbH
oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 5 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Martina Schmitz
- Personal Network
